OptimizeRx Corporation

NASDAQ: OPRX · Real-Time Price · USD
16.91
-0.68 (-3.87%)
At close: Aug 15, 2025, 12:13 PM

OptimizeRx Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
104.75M 94.36M 92.13M 88.18M 83.2M 78.21M 71.52M 62.81M 61.56M 61.72M 62.45M 63.11M 64.15M 63.79M 61.29M 57.41M 51.8M 46.96M
Cost of Revenue
37.3M 33.85M 32.75M 32.98M 31.65M 30.54M 28.62M 25.29M 24.43M 23.42M 23.48M 24.2M 25.59M 26.18M 25.65M 25.56M 23.01M 21.07M
Gross Profit
67.45M 60.52M 59.38M 55.2M 51.55M 47.67M 42.9M 37.51M 37.13M 38.3M 38.97M 38.9M 38.56M 37.62M 35.64M 31.85M 28.79M 25.89M
Operating Income
-3.85M -10.79M -13.71M -28.24M -23.23M -24.37M -26.4M -16.36M -16.57M -15.59M -12.29M -10.81M -7.01M -2.76M 361.1K 1.1M 881.58K -514.38K
Interest Income
383K 399K 331K 350.61K 931.8K 1.55M 2.19M 2.61M 2.21M 1.52M 852.3K 316.17K 27.91K 16.05K 16.98K 15.29K 17.81K 14.19K
Pretax Income
-9.3M -16.11M -19.38M -33.33M -26.26M -25.32M -25.16M -13.75M -14.35M -14.08M -11.44M -10.49M -6.98M -2.75M 378.08K 1.11M 789K -640.57K
Net Income
-9.87M -15.41M -20.11M -24.17M -17.91M -18.07M -17.57M -13.21M -13.52M -13.22M -10.59M -10.18M -6.96M -2.75M 378.08K 1.11M 789K -640.57K
Selling & General & Admin
59.46M 59.46M 61.27M 58.56M 58.02M 55.88M 53.75M 53.42M 52.67M 52.3M 49.66M 46.24M 42.18M 37.24M 31.77M 28.11M 24.91M 22.84M
Research & Development
253K 324K 304K 376K 333K 262K 239K 96K 48K 48K n/a n/a n/a n/a n/a -626.53K -48.48K 558.52K
Other Expenses
10.52M 11.52M 11.51M 24.51M 16.43M 15.43M 14.43M -519.75K 102.93K 1.12M 3.98M 4.43M 4.34M 4.09M 2.09M 3.27M 3.05M 3M
Operating Expenses
70.23M 71.31M 73.08M 83.44M 74.78M 72.04M 69.3M 53.88M 53.7M 53.89M 51.26M 49.71M 45.57M 40.38M 35.28M 30.75M 27.91M 26.4M
Interest Expense
5.99M 5.91M 6.16M 6.05M 4.53M 3M 1.45M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a -776.95K -576.27K -235.64K -199.53K 884.29K 1.02M 936.44K 1.03M 826.66K 590.18K 565.41K
Cost & Expenses
108.6M 105.16M 105.83M 116.42M 106.44M 102.58M 97.92M 79.17M 78.13M 77.31M 74.74M 73.91M 71.16M 66.56M 60.93M 56.31M 50.92M 47.47M
Income Tax Expense
565K -704K 725K -9.16M -8.34M -7.25M -7.6M -538.51K -828.47K -852.29K -852.3K -313.79K -23.82K -3 n/a n/a n/a n/a
Shares Outstanding (Basic)
18.51M 18.47M 18.42M 18.32M 18.26M 18.17M 18.16M 16.64M 16.99M 17.09M 17.07M 17.98M 18.12M 17.88M 17.64M 17.64M 17.35M 15.93M
Shares Outstanding (Diluted)
19.02M 18.47M 18.42M 18.32M 18.26M 18.17M 18.16M 16.64M 16.99M 17.09M 17.07M 17.98M 18.12M 17.88M 18.2M 18.2M 18.1M 16.1M
EPS (Basic)
-0.54 -0.84 -1.1 -1.33 -1 -1.02 -1.01 -0.77 -0.78 -0.75 -0.59 -0.56 -0.38 -0.15 0.02 0.07 0.05 -0.04
EPS (Diluted)
-0.54 -0.84 -1.1 -1.33 -1 -1.02 -1.01 -0.77 -0.78 -0.75 -0.59 -0.57 -0.38 -0.15 0.02 0.06 0.04 -0.05
EBITDA
1.04M -5.84M -8.89M -23.04M -18.8M -20M -22M -13.13M -13.28M -12.91M -10.27M -8.76M -4.96M -1.29M 1.89M 2.66M 2.44M 1.55M
EBIT
-3.32M -10.2M -13.22M -27.28M -22.42M -23.01M -24.4M -14.98M -15.18M -14.93M -12.29M -10.81M -7.01M -2.75M 373.99K 1.22M 898.19K -531.38K
Depreciation & Amortization
4.36M 4.36M 4.33M 4.24M 3.61M 3M 2.4M 1.85M 1.9M 2.01M 2.02M 2.07M 2.08M 2.03M 2.09M 1.99M 1.98M 1.98M